C167 Pill - white capsule/oblong, 17mm
Pill with imprint C167 is White, Capsule/Oblong and has been identified as Lamivudine 300 mg. It is supplied by Cipla USA Inc.
Lamivudine is used in the treatment of Hepatitis B; HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C167
Lamivudine
- Imprint
- C167
- Strength
- 300 mg
- Color
- White
- Size
- 17.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- National Drug Code (NDC)
- 69097-0167
- Inactive Ingredients
-
hypromellose 2910 (15 mPa.s),
magnesium stearate,
microcrystalline cellulose,
sodium starch glycolate type B potato,
polyethylene glycol 6000,
corn starch,
titanium dioxide
Note: Inactive ingredients may vary.
More about lamivudine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
